The digital fix for addiction
You’ve heard about the opioid epidemic by now; last week an Ohio police department posted a controversial and haunting image to show “what [they] are now dealing with on a daily basis"—3K died from overdoses last year in Ohio alone. We’re enormously proud of portfolio company Chrono Therapeutics’ novel approach to combatting addiction (starting with nicotine)—and thrilled to announce they've raised an additional $47.6M in funding.
PS: Here's a cool new tool from Pew to map prescription drug use.
How To Make A Smartphone Detect Anemia
Tweet | Technology Review
Doctors Struggle To Tug Hospital ICUs Into The Modern Era
Tweet | STAT
Amazon Is A Giant Purveyor Of Medical Quackery
Tweet | Vox
With Wearable Tech Deals, New Player Data Is Up For Grabs
Tweet | The New York Times
Doctors Battle Burnout To Save Themselves–And Their Patients
Tweet | US News
5 Reasons Why No One Has Built A Better EpiPen
Tweet | STAT
ITC Says Fitbit Can Try To Block Jawbone From Selling In US
Tweet | MobiHealthNews
US Health Law Faces Critical Year
Tweet | The Wall Street Journal
|Chrono Therapeutics||$47.6M||Kaiser Permanente Ventures, Cota Capital, Emergent Medical Partners, Mission Bay Capital, Canaan Partners, 5AM Ventures, Fountain Health Partners, GE Ventures, Mayo Clinic||Forbes|
|PillPack||$31.1M||Astral Capital, Accomplice, Accel Partners, Charles River Ventures, Sherpa Capital||Fortune|
Get the full roundup of digital health funding deals since 2011. Subscribe to our funding database.